Show simple item record

dc.creatorWolf A.
dc.creatorKhimani F.
dc.creatorYoon B.
dc.creatorGerhart C.
dc.creatorEndsley D.
dc.creatorRay A.K.
dc.creatorYango A.F.
dc.creatorFlynn S.D.
dc.creatorLip G.Y.H.
dc.creatorGonzalez S.A.
dc.creatorSathyamoorthy M.
dc.date.accessioned2022-09-28T17:57:02Z
dc.date.available2022-09-28T17:57:02Z
dc.date.issued2022
dc.identifier.urihttps://doi.org/10.1016/j.tru.2022.100110
dc.identifier.urihttps://repository.tcu.edu/handle/116099117/55824
dc.description.abstractIt is now well established that infection with SARS-CoV-2 resulting in COVID-19 disease includes a severely symptomatic subset of patients in whom an aggressive and/or dysregulated host immune response leads to cytokine storm syndrome (CSS) that may be further complicated by thrombotic events, contributing to the severe morbidity and mortality observed in COVID-19. This review provides a brief overview of cytokine storm in COVID-19, and then presents a mechanistic discussion of how cytokine storm affects integrated pathways in thrombosis involving the endothelium, platelets, the coagulation cascade, eicosanoids, auto-antibody mediated thrombosis, and the fibrinolytic system. © 2022 The Authors
dc.languageen
dc.publisherElsevier
dc.rights2022 The Authors
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceThrombosis Update
dc.subjectClots
dc.subjectCoagulopathy
dc.subjectCOVID-19
dc.subjectCytokine storm
dc.subjectSARS-CoV2
dc.subjectThrombosis
dc.titleThe mechanistic basis linking cytokine storm to thrombosis in COVID-19
dc.typeReview
dc.rights.licenseCC BY-NC-ND 4.0
local.collegeBurnett School of Medicine
local.departmentBurnett School of Medicine
local.personsAll (SOM)


Files in this item

Thumbnail
This item appears in the following Collection(s)

Show simple item record

2022 The Authors
Except where otherwise noted, this item's license is described as 2022 The Authors